Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Shares Issued: 2014-2024

Historic Shares Issued for Neurogene (NGNE) over the last 11 years, with Dec 2024 value amounting to $189.6 million.

  • Neurogene's Shares Issued rose 6692.31% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.2 million, marking a year-over-year increase of 112.29%. This contributed to the annual value of $189.6 million for FY2024, which is 105.31% up from last year.
  • According to the latest figures from FY2024, Neurogene's Shares Issued is $189.6 million, which was up 105.31% from $92.3 million recorded in FY2023.
  • Neurogene's Shares Issued's 5-year high stood at $189.6 million during FY2024, with a 5-year trough of $73,000 in FY2022.
  • In the last 3 years, Neurogene's Shares Issued had a median value of $92.3 million in 2023 and averaged $94.0 million.
  • In the last 5 years, Neurogene's Shares Issued slumped by 99.43% in 2021 and then surged by 126,397.26% in 2023.
  • Neurogene's Shares Issued (Yearly) stood at $71.7 million in 2020, then slumped by 99.43% to $411,000 in 2021, then plummeted by 82.24% to $73,000 in 2022, then spiked by 126,397.26% to $92.3 million in 2023, then spiked by 105.31% to $189.6 million in 2024.